147 related articles for article (PubMed ID: 15208000)
1. Comparison of t-PA and u-PA levels in maximal treadmill and deep-water running.
Ohkuwa T; Itoh H; Yamamoto T; Yamazaki Y
Prev Med; 2004 Jul; 39(1):177-81. PubMed ID: 15208000
[TBL] [Abstract][Full Text] [Related]
2. Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasma.
Dooijewaard G; de Boer A; Turion PN; Cohen AF; Breimer DD; Kluft C
Thromb Haemost; 1991 Jan; 65(1):82-6. PubMed ID: 1902597
[TBL] [Abstract][Full Text] [Related]
3. Differences in u-PA and t-PA increase during acute exercise: relation with exercise parameters.
van den Burg PJ; Dooijewaard G; van Vliet M; Mosterd WL; Kluft C; Huisveld IA
Thromb Haemost; 1994 Feb; 71(2):236-9. PubMed ID: 8191405
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
Koh SC; Yuen R; Viegas OA; Chua SE; Ng BL; Sen DK; Ratnam SS
Thromb Haemost; 1991 Nov; 66(5):581-5. PubMed ID: 1803623
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
Tran-Thang C; Fasel-Felley J; Pralong G; Hofstetter JR; Bachmann F; Kruithof EK
Thromb Haemost; 1989 Sep; 62(2):651-3. PubMed ID: 2510345
[TBL] [Abstract][Full Text] [Related]
6. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.
Schaefer U; Vorlova S; Machida T; Melchor JP; Strickland S; Levi R
J Pharmacol Exp Ther; 2007 Jul; 322(1):265-73. PubMed ID: 17429057
[TBL] [Abstract][Full Text] [Related]
7. Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer.
Grøndahl-Hansen J; Agerlin N; Munkholm-Larsen P; Bach F; Nielsen LS; Dombernowsky P; Danø K
J Lab Clin Med; 1988 Jan; 111(1):42-51. PubMed ID: 3121772
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of free tissue-type and free urokinase-type plasminogen activators in biological fluids by a solid-phase immunoassay.
Kuo BS; Bjornsson TD
Anal Biochem; 1993 Feb; 209(1):70-8. PubMed ID: 8465964
[TBL] [Abstract][Full Text] [Related]
9. Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator.
van Griensven JM; Huisman LG; Stuurman T; Dooijewaard G; Kroon R; Schoemaker RC; Kluft K; Cohen AF
Clin Pharmacol Ther; 1996 Nov; 60(5):504-11. PubMed ID: 8941023
[TBL] [Abstract][Full Text] [Related]
10. Possible role of the plasminogen activation system in human subfertility.
Ebisch IM; Steegers-Theunissen RP; Sweep FC; Zielhuis GA; Geurts-Moespot A; Thomas CM
Fertil Steril; 2007 Mar; 87(3):619-26. PubMed ID: 17123524
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activators in human nasal polyps and mucosa.
Larsen K; de Maat MP; Jespersen J
Rhinology; 1997 Dec; 35(4):175-7. PubMed ID: 9532638
[TBL] [Abstract][Full Text] [Related]
12. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator system in smokers and non-smokers with and without periodontal disease.
Buduneli N; Buduneli E; Kardeşler L; Lappin D; Kinane DF
J Clin Periodontol; 2005 Apr; 32(4):417-24. PubMed ID: 15811061
[TBL] [Abstract][Full Text] [Related]
14. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
Páramo JA; Alfaro MJ; Rocha E
Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269
[TBL] [Abstract][Full Text] [Related]
15. Plasma catecholamine and blood lactate cumulation during incremental exhaustive exercise.
Lehmann M; Schmid P; Keul J
Int J Sports Med; 1985 Apr; 6(2):78-81. PubMed ID: 4008144
[TBL] [Abstract][Full Text] [Related]
16. Rt-PA causes a significant increase in endogenous u-PA during experimental focal cerebral ischemia.
Burggraf D; Martens HK; Wunderlich N; Jäger G; Hamann GF
Eur J Neurosci; 2004 Dec; 20(11):2903-8. PubMed ID: 15579144
[TBL] [Abstract][Full Text] [Related]
17. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis.
Wankiewicz A; Iwan-Zietek I; Kotschy M; Gwieździński Z
Med Sci Monit; 2002 Mar; 8(3):CR189-92. PubMed ID: 11887034
[TBL] [Abstract][Full Text] [Related]
18. Secretion of tissue plasminogen activator and plasminogen activator inhibitor 1 during cardiopulmonary bypass.
Chandler WL; Velan T
Thromb Res; 2003; 112(3):185-92. PubMed ID: 14967416
[TBL] [Abstract][Full Text] [Related]
19. [Tissue and urokinase plasminogen activators (t-PA, u-PA) and their inhibitor PAI-1 in blood of patients with laryngeal neoplasms].
Białkowska A; Kotschy M; Betlejewski S; Burduk D
Otolaryngol Pol; 1995; 49 Suppl 20():84-7. PubMed ID: 9454229
[TBL] [Abstract][Full Text] [Related]
20. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]